Alumis Statistics
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.77-0.16 (-2.31%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Alumis by the numbers
Alumis has a market capitalization of $876.3 million based on 129.44M shares outstanding. With trailing EPS of $-3.86, Alumis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 59.9% below its 50-day average and 69.3% below its 200-day average.
Average daily trading volume is 2.44M shares, or about $16.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALMS valuation vs. peer median
| Metric | ALMS | Peer median | Difference |
|---|---|---|---|
| Market cap | $876.28M | $900.62M | -3% |
| Avg. volume | 2.44M | 753.51K | +224% |
Peer median across 8 companies: RIGL, ANL, CYRX, MLTX, JBIO, CRVS, ANRO, KURA.
Valuation
- Market cap
- $876.28M
- EPS (TTM)
- $-3.86
- Shares outstanding
- 129.44M
Price and trading
- Previous close
- 6.93
- Open
- 6.82
- Day range
- 6.71 – 6.95
- 52-week range
- 4.28 – 31.35
- 52-week change
- +50.11%
- Beta
- —
- Volume
- 2.17M
- Average volume
- 2.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 876.28M
- Forward Pe
- -2.36
- Eps
- -3.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.35
- Week52 Low
- 4.28
- Avg Volume
- 2.44M
- Shares Outstanding
- 129.44M
- Ma50
- 16.89
- Ma200
- 22.09
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -78.41%
- Pct From52w Low
- 58.36%